The frequency of toll-like receptor 4 gene polymorphism in ankylosing spondylitis and its relationship between disease activity
暂无分享,去创建一个
O. Ozdemır | A. Akbal | C. Zateri | F. Sılan | H. Reşorlu | Y. Savaş | Betül Sargin
[1] I. Briceño,et al. The Frequency of HLA-B27 in a Colombian Population with Signs of Spondyloarthritis. , 2017, Current rheumatology reviews.
[2] D. Baeten,et al. Serum IgA Immune Complexes Promote Proinflammatory Cytokine Production by Human Macrophages, Monocytes, and Kupffer Cells through FcαRI–TLR Cross-Talk , 2017, The Journal of Immunology.
[3] M. Borawska,et al. Concentration of selenium, zinc, copper, Cu/Zn ratio, total antioxidant status and c-reactive protein in the serum of patients with psoriasis treated by narrow-band ultraviolet B phototherapy: A case-control study. , 2017, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[4] Zheng Zhang,et al. Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system. , 2017, Vaccine.
[5] A. Kratz,et al. ICSH recommendations for modified and alternate methods measuring the erythrocyte sedimentation rate , 2017, International journal of laboratory hematology.
[6] E. Tinazzi,et al. Gene Expression Analysis before and after Treatment with Adalimumab in Patients with Ankylosing Spondylitis Identifies Molecular Pathways Associated with Response to Therapy , 2017, Genes.
[7] M. Mahmoudi,et al. New insights toward the pathogenesis of ankylosing spondylitis; genetic variations and epigenetic modifications , 2017, Modern rheumatology.
[8] V. Calvo,et al. Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing. , 2016, Translational lung cancer research.
[9] Zhiming Lin,et al. Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial , 2016, Trials.
[10] M. Mahmoudi,et al. Gene Expression Profiling of Toll-Like Receptor 4 and 5 in Peripheral Blood Mononuclear Cells in Rheumatic Disorders: Ankylosing Spondylitis and Rheumatoid Arthritis. , 2016, Iranian journal of allergy, asthma, and immunology.
[11] A. Amini,et al. Erythrocyte Sedimentation Rate Measurement Using as a Rapid Alternative to the Westergren Method , 2015, Emergency.
[12] A. Akbal,et al. C-reactive protein gene and Toll-like receptor 4 gene polymorphisms can relate to the development of psoriatic arthritis , 2015, Clinical Rheumatology.
[13] D. Ye,et al. Lack of association of TLR4 polymorphisms with susceptibility to rheumatoid arthritis and ankylosing spondylitis: a meta-analysis. , 2012, Joint, bone, spine : revue du rhumatisme.
[14] M. Mayes,et al. Whole-blood Gene Expression Profiling in Ankylosing Spondylitis Shows Upregulation of Toll-like Receptor 4 and 5 , 2011, The Journal of Rheumatology.
[15] L. Bradbury,et al. Toll-like receptor 4 and CD14 polymorphisms in ankylosing spondylitis: evidence of a weak association in Finns. , 2008, The Journal of rheumatology.
[16] P. Rahman,et al. Analysis of single nucleotide polymorphisms in Toll-like receptor 4 shows no association with ankylosing spondylitis in a Korean population , 2008, Rheumatology International.
[17] L-Z Zhang,et al. Increased expression of Toll-like receptor 4 in peripheral blood leucocytes and serum levels of some cytokines in patients with ankylosing spondylitis. , 2007 .
[18] C. Greenwood,et al. Association of toll-like receptor 4 variants and ankylosing spondylitis: a case-control study. , 2007, The Journal of rheumatology.
[19] G. Poór,et al. Lack of genetic association of the Toll-like receptor 4 (TLR4) Asp299Gly and Thr399Ile polymorphisms with spondylarthropathies in a Hungarian population. , 2006, Rheumatology.
[20] J. Gracie,et al. TLR4 mutations (Asp299Gly and Thr399Ile) are not associated with ankylosing spondylitis , 2006, Annals of the rheumatic diseases.
[21] Dominique Baeten,et al. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy. , 2005, Arthritis and rheumatism.
[22] B. Dijkmans,et al. No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis , 2005, Annals of the rheumatic diseases.
[23] D. Baeten,et al. Increased systemic and local expression of toll-like receptor 2 and 4 in spondyloarthropathy is downmodulated by tumour necrosis factor alpha blockade , 2005 .